Analyst Upgrades and Downgrades For the Week of November 25th

Upgrades – Tuesday, November 26, 2024

• Applied Industrial (AIT): BofA Securities, Neutral >> Buy, Price Target: $285 >> $315
• Charter Comm (CHTR): Exane BNP Paribas, Underperform >> Neutral, Price Target: $360
• Capri Holdings (CPRI): Guggenheim, Neutral >> Buy, Price Target: $30
• Chevron (CVX): Citigroup, Neutral >> Buy, Price Target: $145 >> $185
• Eastman Chemical (EMN): Wells Fargo, Equal Weight >> Overweight, Price Target: $110 >> $125
• First Interstate Bancsystem (FIBK): DA Davidson, Neutral >> Buy, Price Target: $32 >> $42
• Hanesbrands (HBI): UBS, Neutral >> Buy, Price Target: $9 >> $11
• NRG Energy (NRG): Jefferies, Hold >> Buy, Price Target: $93 >> $113
• Old National Bancorp (ONB): Raymond James, Mkt Perform >> Strong Buy, Price Target: $28
• Science Applications (SAIC): Wells Fargo, Equal Weight >> Overweight, Price Target: $157 >> $147
• Banco Santander (SAN): Morgan Stanley, Equal-Weight >> Overweight
• Zoom Video (ZM): Evercore ISI, In-line >> Outperform, Price Target: $70 >> $115
• L3Harris (LHX): Argus, Hold >> Buy, Price Target: $300
• Grupo Aeroportuario del Pacifico (PAC): UBS, Neutral >> Buy
• LexinFintech (LX): Citigroup, Neutral >> Buy

---

Downgrades – Tuesday, November 26, 2024

• American Airlines (AAL): UBS, Buy >> Neutral, Price Target: $16
• Brunswick (BC): B. Riley Securities, Buy >> Neutral, Price Target: $95 >> $88
• Everest Group (EG): Jefferies, Buy >> Hold, Price Target: $420 >> $429
• GMS (GMS): DA Davidson, Buy >> Neutral, Price Target: $97
• Goldman Sachs (GS): HSBC Securities, Buy >> Hold, Price Target: $569 >> $608
• Hubbell (HUBB): Deutsche Bank, Buy >> Hold, Price Target: $493 >> $473
• Morgan Stanley (MS): HSBC Securities, Buy >> Hold
• ING Groep (ING): Morgan Stanley, Overweight >> Equal-Weight
• Cassava Sciences (SAVA): H.C. Wainwright, Buy >> Neutral
• Target (TGT): Daiwa Securities, Outperform >> Neutral, Price Target: $170 >> $130
• Alector (ALEC): Morgan Stanley, Equal-Weight >> Underweight, Price Target: $10 >> $3
• Kohl’s (KSS): Gordon Haskett, Hold >> Reduce, Price Target: $11

---

Coverage Initiated – Tuesday, November 26, 2024

• Aurora Innovation (AUR): Wolfe Research, Peer Perform
• Carnival (CCL): Bernstein, Mkt Perform, Price Target: $26
• CARGO Therapeutics (CRGX): William Blair, Outperform
• Bright Minds Biosciences (DRUG): Robert W. Baird, Outperform, Price Target: $75
• Dyne Therapeutics (DYN): RBC Capital Mkts, Outperform, Price Target: $45
• Ingram Micro Holding Corp. (INGM): Melius, Hold, Price Target: $26
• Kornit Digital (KRNT): Cantor Fitzgerald, Overweight, Price Target: $39
• Pinterest (PINS): TD Cowen, Buy, Price Target: $38
• Pentair (PNR): Wolfe Research, Outperform, Price Target: $125
• Royal Caribbean (RCL): Bernstein, Outperform, Price Target: $290
• Redwire Corporation (RDW): H.C. Wainwright, Buy, Price Target: $18
• Rambus (RMBS): Robert W. Baird, Outperform, Price Target: $90
• Avidity Biosciences (RNA): RBC Capital Mkts, Outperform, Price Target: $67
• Sonoco Products (SON): Truist, Buy, Price Target: $63
• Thomson Reuters (TRI): Wells Fargo, Equal Weight, Price Target: $165
• Century Casinos (CNTY): Craig Hallum, Buy, Price Target: $8
• Viper Energy Partners (VNOM): BofA Securities, Buy, Price Target: $64

---

Upgrades (Monday, November 25, 2024)

• Banco Santander Brasil (BSBR)
  • Brokerage: JP Morgan
  • Rating: Neutral → Overweight
  • Price Target: $6 → $7
• Equinor (EQNR)
  • Brokerage: Barclays
  • Rating: Equal Weight → Overweight
• Elastic (ESTC)
  • Brokerage: Wedbush
  • Rating: Neutral → Outperform
  • Price Target: $135
• Robinhood Markets (HOOD)
  • Brokerage: Morgan Stanley
  • Rating: Equal-Weight → Overweight
  • Price Target: $24 → $55
• Jones Lang LaSalle (JLL)
  • Brokerage: Wolfe Research
  • Rating: Peer Perform → Outperform
  • Price Target: $353
• KinderCare Learning Companies (KLC)
  • Brokerage: Morgan Stanley
  • Rating: Equal-Weight → Overweight
  • Price Target: $30
• Procter & Gamble (PG)
  • Brokerage: DA Davidson
  • Rating: Neutral → Buy
  • Price Target: $160 → $209
• Sally Beauty (SBH)
  • Brokerage: TD Cowen
  • Rating: Hold → Buy
  • Price Target: $14 → $16
• Synchronoss Technologies (SNCR)
  • Brokerage: ROTH MKM
  • Rating: Neutral → Buy
  • Price Target: $11 → $13
• Snowflake (SNOW)
  • Brokerage: Wedbush
  • Rating: Neutral → Outperform
  • Price Target: $190
• The Trade Desk (TTD)
  • Brokerage: New Street
  • Rating: Sell → Neutral
  • Price Target: $85 → $115
• U.S. Bancorp (USB)
  • Brokerage: Citigroup
  • Rating: Neutral → Buy
  • Price Target: $49 → $65
• W.R. Berkley (WRB)
  • Brokerage: Goldman Sachs
  • Rating: Neutral → Buy
  • Price Target: $69

---

Downgrades (Monday, November 25, 2024)

• Arthur J. Gallagher (AJG)
  • Brokerage: Goldman Sachs
  • Rating: Buy → Neutral
  • Price Target: $313
• Banco Bradesco (BBD)
  • Brokerage: JP Morgan
  • Rating: Overweight → Neutral
• Perspective Therapeutics (CATX)
  • Brokerage: BofA Securities
  • Rating: Buy → Neutral
  • Price Target: $24 → $5
• Community Health (CYH)
  • Brokerage: Wells Fargo
  • Rating: Equal Weight → Underweight
  • Price Target: $5 → $2.5
• Despegar.com (DESP)
  • Brokerage: TD Cowen
  • Rating: Buy → Sell
  • Price Target: $12 → $14
• Editas Medicine (EDIT)
  • Brokerage: BofA Securities
  • Rating: Buy → Underperform
  • Price Target: $13 → $1
• Expensify (EXFY)
  • Brokerage: JMP Securities
  • Rating: Market Outperform → Market Perform
• Eagle Materials (EXP)
  • Brokerage: Loop Capital
  • Rating: Buy → Hold
  • Price Target: $315
• Five Below (FIVE)
  • Brokerage: Telsey Advisory Group
  • Rating: Outperform → Market Perform
  • Price Target: $102 → $95
• HCA (HCA)
  • Brokerage: Wells Fargo
  • Rating: Equal Weight → Underweight
  • Price Target: $400 → $320
• M&T Bank (MTB)
  • Brokerage: Citigroup
  • Rating: Buy → Neutral
  • Price Target: $220 → $230
• Mainz Biomed B.V. (MYNZ)
  • Brokerage: H.C. Wainwright
  • Rating: Buy → Neutral
• NIO (NIO)
  • Brokerage: Goldman Sachs
  • Rating: Neutral → Sell
  • Price Target: $4.8 → $3.9
• Newmark Group (NMRK)
  • Brokerage: Wolfe Research
  • Rating: Outperform → Peer Perform
• Red Rock Resorts (RRR)
  • Brokerage: Mizuho
  • Rating: Outperform → Neutral
  • Price Target: $57 → $44
• Smith Douglas Homes Corp (SDHC)
  • Brokerage: JP Morgan
  • Rating: Overweight → Neutral
  • Price Target: $41 → $36
• Select Medical (SEM)
  • Brokerage: The Benchmark Company
  • Rating: Buy → Hold
• Block (SQ)
  • Brokerage: BMO Capital Markets
  • Rating: Outperform → Market Perform
  • Price Target: $94 → $100
• Tenet Healthcare (THC)
  • Brokerage: Wells Fargo
  • Rating: Overweight → Equal Weight
  • Price Target: $205 → $150
• Baidu (BIDU)
  • Brokerage: Susquehanna
  • Rating: Positive → Neutral
  • Price Target: $105 → $85
• Barrick Gold (GOLD)
  • Brokerage: CIBC
  • Rating: Sector Outperform → Neutral
• Baidu (BIDU)
  • Brokerage: China Renaissance
  • Rating: Buy → Hold
  • Price Target: $86
• Xos (XOS)
  • Brokerage: Northland Capital
  • Rating: Outperform → Market Perform
  • Price Target: $5

---

Coverage Initiated (Monday, November 25, 2024)

• Apogee Therapeutics (APGE)
  • Brokerage: Canaccord Genuity
  • Rating: Buy
  • Price Target: $89
• Arm Holdings plc (ARM)
  • Brokerage: UBS
  • Rating: Buy
  • Price Target: $160
• Brown-Forman (BF.B)
  • Brokerage: Exane BNP Paribas
  • Rating: Outperform
  • Price Target: $48
• Coursera (COUR)
  • Brokerage: JP Morgan
  • Rating: Neutral
  • Price Target: $8
• CSW Industrials (CSWI)
  • Brokerage: Wells Fargo
  • Rating: Equal Weight
  • Price Target: $425
• Immunic (IMUX)
  • Brokerage: H.C. Wainwright
  • Rating: Buy
  • Price Target: $10
• Manhattan Associates (MANH)
  • Brokerage: Piper Sandler
  • Rating: Overweight
  • Price Target: $326
• MARA Holdings Inc. (MARA)
  • Brokerage: Barclays
  • Rating: Equal Weight
  • Price Target: $27
• Shoals Technologies (SHLS)
  • Brokerage: BofA Securities
  • Rating: Buy
  • Price Target: $6
• SPS Commerce (SPSC)
  • Brokerage: Piper Sandler
  • Rating: Neutral
  • Price Target: $198
• SPX Technologies (SPXC)
  • Brokerage: Wolfe Research
  • Rating: Outperform
  • Price Target: $199